drugset / Trial / NCT00472953
Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe, Asia and South America. A one-year clinical trial to compare the safety of inhaled human insulin to subcutaneous insulin aspart in subjects with type 1 or type 2 diabetes and chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2007-05-15
- Primary completion
- 2008-03-05
- Completion
- 2008-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |